A randomized phase 3 study of allogeneic HCT with Iomab-B versus conventional care in older patients with active, relapsed/refractory AML: Pivotal SIERRA trial results Meeting Abstract
| Authors: | Giralt, S.; Gyurkocza, B.; Seropian, S.; Choe, H.; Litzow, M.; Abboud, C.; Koshy, N.; Stiff, P.; Tomlinson, B.; Abhyankar, S.; Foran, J.; Hari, P.; Chen, G.; Al-Kadhimi, Z.; Kebriaei, P.; Sabloff, M.; Orozco, J.; Jamieson, K.; Magalhaes-Silverman, M.; Van Besien, K.; Schuster, M.; Law, A.; Abedin, S.; Larkin, K.; Rowley, S.; Munshi, P.; Cook, R.; Mayer, S.; Levy, M. Y.; Lazarus, H.; Sandmaier, B.; Reddy, V.; Spross, J.; McNamara, K.; Haeuber, E.; Nahar, A.; Pagel, J.; Desai, A.; Nath, R. |
| Abstract Title: | A randomized phase 3 study of allogeneic HCT with Iomab-B versus conventional care in older patients with active, relapsed/refractory AML: Pivotal SIERRA trial results |
| Meeting Title: | 49th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 58 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Apr 23-26 |
| Meeting Location: | Paris, France |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2023-12-01 |
| Start Page: | 50 |
| End Page: | 52 |
| Language: | English |
| ACCESSION: | WOS:001110902800049 |
| PROVIDER: | wos |
| PUBMED: | 37945720 |
| DOI: | 10.1038/s41409-023-02055-8 |
| Notes: | Meeting Abstract: O048 -- Found in section, "Physicians - Oral Sessions" -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
